BIVDA Press Releases

15Jan

BIVDA response to Parliament’s vote on the Brexit deal

Today the House of Commons voted down the EU withdrawal agreement and the framework for the future relationship.

Doris-Ann Williams, BIVDA’s Chief Executive, commented: “Today’s vote casts a shadow of uncertainty over the UK’s future relationship with the EU. The IVD industry remains anxious about access for patients to essential diagnostic tests if there is no transition period after 29 March. We therefore call for positive steps to be taken in these testing times and urge Government and policy makers to provide clarity and create sufficient space for our sector so that it is able to meet the significant challenge of ensuring the supply of essential diagnostics tests to patients through 2019.”

For a copy of BIVDA's position paper on Brexit, click here.

Related

BIVDA Response to Cancer Research UK Report on Pathology Services

Cancer Research UK have today (23 November 2016) published a report which finds that UK pathology se...

Read More >

Joint Industry Press Release - COVID-19 Testing Situation

FOR IMMEDIATE RELEASE "The urgent global need for the components of testing kits and facil...

Read More >

Member Press Release - Lex Diagnostics joins BIVDA

LEX Diagnostics is developing a point-of-care PCR platform that is a major improvement in speed, cos...

Read More >

UN International Day of Women and Girls in Science

BIVDA celebrates International Day of Women and Girls in Science

Read More >

Government Responds to AAR Report – BIVDA’s View

The Government has today (04 November) published its response to the final report of the Accelerated...

Read More >